Strategic healthcare interventions bring Japan close to eliminating hepatitis
Researchers said sustained diagnosis and treatment could cut chronic HBV to about 200,000 cases and HCV to under 20,000 by 2050.
2 Articles
2 Articles
Strategic healthcare interventions bring Japan close to eliminating hepatitis
Hepatitis B (HBV) and hepatitis C (HCV) are viral infections that can lead to health conditions such as cirrhosis, cancer, and potentially death if unmanaged. HBV can be transmitted through sexual contact, blood exposure, and mother-to-child transmission, while HCV is primarily transmitted through blood-to-blood contact.
Long-term hepatitis control efforts dramatically reduce HBV and HCV burden in Japan
Hepatitis B (HBV) and hepatitis C (HCV) are viral infections that can lead to health conditions such as cirrhosis, cancer and death if unmanaged. HBV can be transmitted through sexual contact, blood exposure and mother-to-child transmission, while HCV is primarily transmitted through blood-to-blood contact.

Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium


